Page last updated: 2024-08-24

lamivudine and Liver Failure

lamivudine has been researched along with Liver Failure in 68 studies

Research

Studies (68)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	8 (11.76)	18.2507
2000's	41 (60.29)	29.6817
2010's	19 (27.94)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bohorquez, HE; Bruce, DS; Carmody, IC; Cohen, AJ; Girgrah, N; Joshi, S; Loss, GE; Mason, AL; Reichman, TW; Therapondos, G	1
Chen, H; Fan, C; Gong, Z; Wang, L	1
Chang, ML; Jeng, WJ; Liaw, YF	1
Kim, DY; Kim, KM; Lee, SG; Lee, YJ; Namgoong, JM; Oh, SH; Song, SM	1
Ahmadinejad, Z; Dashti, H; Jafarian, A; Kasraianfard, A; Moini, M; Najafi, A; Nassiri-Toosi, M; Salimi, J	1
Imoto, S; Kim, SK; Kim, SR; Otono, Y; Tamura, T; Tohyama, M	1
Andreone, P; Conti, F; Cucchetti, A; Ercolani, G; Loggi, E; Pinna, AD	1
Dong, C; Gao, W; Ma, N; Shen, ZY; Sun, C; Wang, K; Zheng, WP	1
Hino, T; Hisamochi, A; Ide, T; Koga, H; Koga, Y; Kumashiro, R; Kuwahara, R; Ogata, K; Sata, M; Takao, Y; Tanaka, K	1
Li, SC; Sun, LJ; Yu, JW; Zhao, YH	1
Bak, YT; Byun, KS; Joo, MK; Jung, YK; Kim, JH; Kim, JS; Lee, SJ; Park, JJ; Yeon, JE; Yim, HJ	1
Dorobantu, B; Gangone, E; Gheorghe, L; Hrehoret, D; Iacob, S; Matei, E; Popescu, I	1
Chen, XS; Han, LZ; Luo, Y; Qiu, DK; Shen, CH; Wang, SY; Wang, X; Xi, ZF; Xia, Q; Xin, TY; Zhang, JJ	1
Chen, CW; Chen, CX; Fu, QC; He, CL; Liu, B; Ma, Y; Pan, XN; Wang, MR; Wang, QC; Zhen, RD; Zhou, YJ	1
Kang, P; Li, SC; Sun, LJ; Yu, JW; Zhao, YH	1
Berg, CL; Coffin, CS; Curry, MP; Dove, LM; Nissen, NN; Ragni, M; Regenstein, FG; Roland, ME; Sherman, KE; Stock, PG; Terrault, NA	1
Cui, YL; Feng, P; Lei, XZ; Liu, L; Song, XQ; Tang, H; Wang, YB; Yan, F; Zheng, MH	1
LI, M; WU, JY; Zhang, H	1
Akbas, E; Aktas, S; Atiq, A; Haberal, M; Karakayali, H; Selcuk, H; Sevmis, S; Zia, HH	1
Beebe, S; Bialkowska, J; Brown, RS; Cheinquer, H; Cooney, E; Jeffers, L; Leung, N; Liaw, YF; Myers, RP; Peng, CY; Raptopoulou-Gigi, M; Sarin, SK; Tang, S; Tanwandee, T; Tsai, N	1
Esmaeilzadeh, M; Fonouni, H; Ganten, TM; Golriz, M; Hafezi, M; Majlesara, A; Mehrabi, A; Rad, MT; Rahbari, NN; Sadeghi, M; Schmidt, J	1
Ji, Y; Jiang, H; Ju, L; Kan, N; Wu, K; Yu, M	1
Chang, CY; Hsu, CC; Hsu, CY; Hsu, YC; Huang, SC; Lin, CW; Lin, JT; Lo, GH; Mo, LR; Perng, DS; Tai, CM; Tseng, CH	1
Mao, Q; You, JP; Zhang, HY; Zhang, XQ	1
Avila, C; Bao, W; Chan, HL; Chen, YC; Choudhuri, G; Chutaputti, A; Gane, EJ; Hwang, SG; Piratvisuth, T; Prabhakar, B; Safadi, R; Sarin, SK; Suh, DJ; Tanwandee, T; Trylesinski, A; Yurdaydin, C	1
Camera, A; Chiurazzi, F; D'Arco, AM; Risitano, AM; Rossi, M; Rotoli, B	1
Ayres, A; Bartholomeusz, A; Lam, KC; Lau, G; Lee, JY; Locarnini, S	1
Cheng, VC; Lau, GK; Lo, CM	1
Ciancia, R; De Divitiis, B; De Renzo, A; Del Giudice, A; Pane, F; Persico, M; Picardi, M; Quintarelli, C; Rotoli, B; Salvatore, F	1
Flemming, P; Klempnauer, J; Manns, MP; Nashan, B; Niemann, P; Rohde, P; Tillmann, HL; Tischendorf, JJ; Trautwein, C; Wiegand, J	1
Hino, T; Ide, T; Inoue, H; Koga, Y; Kumashiro, R; Kuwahara, R; Sata, M; Tanabe, R; Tanaka, E	1
Attili, A; Berloco, P; Callejon, V; Ferretti, G; Ferretti, S; Ginanni Corradini, S; Iappelli, M; Lilli, D; Mancini, C; Masini, A; Merli, M; Rivanera, D; Rossi, M; Tanzilli, P	1
Asaka, M; Imamura, M; Kanamori, H; Kawamura, T; Masauzi, N; Miura, T; Obara, S; Saitoh, S; Tanaka, J; Tsutsumi, Y; Yamada, M	1
Kondili, LA; Mutimer, D; Osman, H	1
De Medina, M; Madariaga, J; Montalbano, M; Neff, GW; Nery, C; Nery, J; O'brien, CB; Ruiz, P; Safdar, K; Schiff, ER; Shire, N; Tzakis, AG	1
Gehri, M; Gerner, P; Laubscher, B; Roulet, M; Wirth, S	1
Dimakopoulos, K; Dimou, E; Hadziyannis, SJ; Kitis, G; Manesis, E; Manolakopoulos, S; Papatheodoridis, GV; Rapti, I; Tzourmakliotis, D	1
Chan, SC; Fan, ST; Lau, GK; Liu, CL; Lo, CM; Ng, IO	1
Erb, SR; Ho, JK; Hoskins, PJ; Law, JK; Steinbrecher, UP; Yoshida, EM	1
Gao, DC; Jia, JD; Liu, J; Sun, MC; Wang, BE; Wang, Y; Wu, GC; Wu, P; Zhang, D; Zhang, ZT	1
Brown, RS; Brundage, R; Dickson, RC; Fried, M; Horwith, G; Ishitani, M; Jensen, D; Lok, A; Luketic, V; Reddy, KR; Sheiner, P; Soldevila-Pico, C; Terrault, NA	1
Guan, S; Huang, YX; Lu, M; Roggendorf, M; Wang, XY; Xu, Y; Yin, YK; Zhang, JM	1
Chen, Y; Liang, T; Lu, A; Shen, Y; Wang, W; Zhang, M; Zheng, S	1
Akan, M; Akarsu, M; Astarcioğlu, H; Astarcioğlu, I; Karademir, S; Ozkardesler, S; Ozzeybek, D; Sayiner, A; Tankurt, E	1
Jung, JO; Kim, BG; Kim, YJ; Lee, HS; Yoon, JH	1
Iino, S; Itoh, F; Koike, K; Moriya, K; Nagase, Y; Okuse, C; Suzuki, M; Suzuki, Y; Takahashi, H; Yotsuyanagi, H	1
Bzowej, NH; Han, SH; Ishitani, MB; Lok, AS; Osborn, MK; Regev, A; Tran, TT	1
Araujo, NM; Bottecchia, M; Gomes, SA; Ikuta, N; Niel, C; O, KM	1
Ahmed, M; Beranek, P; Brown, D; Burroughs, AK; Dusheiko, G; Elias, E; Grellier, L; Kennedy, F; Kibbler, H; McMaster, P; McPhillips, P; Mutimer, D; Rolles, K	1
Bain, VG; Fischer, K; Gutfreund, K; Jewell, LD; Kneteman, NM; Lee, H; Ma, MM; Shapiro, JA; Tipples, G; Tyrrell, DL	1
Schalm, SW	1
Bartholomew, MM; Brown, NA; Bunzendahl, H; Condreay, LD; Jansen, RW; Jeffers, LJ; Johnson, LC; Reddy, KR; Schiff, ER; Tzakis, AG	1
Ahmed, A; Cohn, G; Ehrenpreis, ED; Lissoos, TW; Schiano, TD; Siano, C; Zaitman, D	1
Andreone, P; Belli, L; Bernardi, M; Caraceni, P; Cavallari, A; D'Errico, A; Dal Monte, PR; Ercolani, G; Forti, D; Grazi, GL; Ideo, G; Jovine, E; Mazziotti, A; Milandri, GL	1
Bontempo, FA; Dodson, SF; Fung, JJ; Hunt, SC; Ragni, MV	1
Gibbs, CS; Howard, T; Jacobsmeyer, S; Lamy, P; Murray, A; Peters, MG; Singer, G; Xiong, X	1
Keeffe, EB	1
de Man, RA; Honkoop, P; Niesters, HG; Schalm, SW; Zondervan, PE	1
Gondo, H; Himeji, D; Kaji, Y; Niho, Y; Sata, M; Uchida, N	1
Batty, DS; Colonna, JO; Goodman, ZD; Holtzmuller, KC; Ormseth, EJ; Sjogren, MH	1
Bar-Nathan, N; Ben-Ari, Z; Dinari, G; Mor, E; Shapira, R; Sokal, EM; Tur-Kaspa, R	1
Bruno, R; Filice, G; Malfitano, A; Sacchi, P	1
Chan, FK; Chan, HL; Chau, TN; Lai, ST; Leung, NW; Sung, JJ; Tsang, SW	1
Chen, CH; Cheng, CH; Lee, WC; Lian, JD; Shu, KH; Wu, MJ	1
Ayres, A; Bonacini, M; Gibbs, C; Kurz, A; Locarnini, S	1
Chou, YP; Lee, CM; Lee, JF; Lu, SN; Wang, JH	1

Reviews

5 review(s) available for lamivudine and Liver Failure

Article	Year
Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature. World journal of gastroenterology, 2016, Sep-21, Volume: 22, Issue:35 Topics: Antiviral Agents; Graft Survival; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver; Liver Failure; Liver Transplantation; Risk; Tissue Donors	2016
The role of HBIg as hepatitis B reinfection prophylaxis following liver transplantation. Langenbeck's archives of surgery, 2012, Volume: 397, Issue:5 Topics: Antiviral Agents; Combined Modality Therapy; Female; Graft Rejection; Graft Survival; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Failure; Liver Transplantation; Male; Postoperative Care; Prognosis; Risk Assessment; Secondary Prevention; Survival Analysis; Treatment Outcome	2012
Current issues and treatment of fulminant hepatic failure including transplantation in Hong Kong and the Far East. Seminars in liver disease, 2003, Volume: 23, Issue:3 Topics: Asia, Eastern; Hepatitis B; Hong Kong; Humans; Immunotherapy, Adoptive; Lamivudine; Liver Failure; Liver Transplantation; Reverse Transcriptase Inhibitors	2003
End-stage liver disease and liver transplantation: role of lamivudine therapy in patients with chronic hepatitis B. Journal of medical virology, 2000, Volume: 61, Issue:3 Topics: Antiviral Agents; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure; Liver Transplantation; Treatment Outcome	2000
Hepatic decompensation associated with lamivudine: a case report and review of lamivudine-induced hepatotoxicity. The American journal of gastroenterology, 2001, Volume: 96, Issue:5 Topics: Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Failure; Liver Transplantation; Male; Middle Aged; Reverse Transcriptase Inhibitors	2001

Trials

15 trial(s) available for lamivudine and Liver Failure

Article	Year
Efficacy and safety of telbivudine therapy in liver failure patients with chronic hepatitis B virus infection. Journal of medical virology, 2013, Volume: 85, Issue:11 Topics: Adolescent; Adult; Aged; Antiviral Agents; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure; Liver Function Tests; Longitudinal Studies; Male; Middle Aged; Telbivudine; Thymidine; Treatment Outcome; Viral Load; Young Adult	2013
Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment. Journal of gastroenterology and hepatology, 2008, Volume: 23, Issue:8 Pt 1 Topics: Acute Disease; Adult; Antiviral Agents; Female; Forecasting; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Models, Biological; Plasma Exchange; Predictive Value of Tests; Prognosis; Severity of Illness Index	2008
The role of entecavir in preventing hepatitis B recurrence after liver transplantation. Journal of digestive diseases, 2009, Volume: 10, Issue:4 Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Female; Follow-Up Studies; Guanine; Hepatitis Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Reverse Transcriptase Inhibitors; Secondary Prevention	2009
The study of efficacy of lamivudine in patients with severe acute hepatitis B. Digestive diseases and sciences, 2010, Volume: 55, Issue:3 Topics: Acute Disease; Adult; Aged; Anti-HIV Agents; Bilirubin; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Proportional Hazards Models	2010
Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure. Digestive diseases and sciences, 2010, Volume: 55, Issue:8 Topics: Adult; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome	2010
[Effect of glucocorticoid treatment on the clinical outcome of patients with early-stage liver failure]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2011, Volume: 31, Issue:3 Topics: Adult; Female; Glucocorticoids; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Treatment Outcome; Young Adult	2011
Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study. Hepatology (Baltimore, Md.), 2011, Volume: 54, Issue:1 Topics: Adenine; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Drug Resistance, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Organophosphonates; Survival Rate; Treatment Outcome	2011
Efficacy of peripartum antiviral treatment for hepatic failure due to hepatitis B virus. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2011, Volume: 114, Issue:1 Topics: Adult; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B; Hepatitis B e Antigens; Humans; Infant, Newborn; Lamivudine; Liver Failure; Maternal Mortality; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Time Factors; Treatment Outcome; Uterine Diseases; Virus Replication; Young Adult	2011
Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis. Journal of viral hepatitis, 2012, Volume: 19, Issue:10 Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Double-Blind Method; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Failure; Male; Middle Aged; Multicenter Studies as Topic; Nucleosides; Prospective Studies; Pyrimidinones; Severity of Illness Index; Telbivudine; Thymidine; Treatment Outcome; Young Adult	2012
Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2005, Volume: 11, Issue:7 Topics: Adenine; Adult; Aged; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Mutation; Organophosphonates; Protein Structure, Tertiary; Reverse Transcriptase Inhibitors; Treatment Outcome	2005
Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2006, Volume: 12, Issue:1 Topics: Adult; Aged; Analysis of Variance; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Hepatitis B Antibodies; Hepatitis B, Chronic; Humans; Immunoglobulins; Infusions, Intravenous; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Risk Assessment; Secondary Prevention; Transplantation Immunology; Treatment Outcome	2006
High rates of progressive hepatic functional deterioration whether lamivudine therapy is continued or discontinued after emergence of a lamivudine-resistant mutant: a prospective randomized controlled study. Journal of gastroenterology, 2006, Volume: 41, Issue:3 Topics: Adolescent; Adult; Aged; Alanine Transaminase; Bilirubin; Biomarkers; Disease Progression; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Korea; Lamivudine; Liver Failure; Male; Middle Aged; Multivariate Analysis; Mutation; Platelet Count; Predictive Value of Tests; Prospective Studies; Prothrombin Time; Reverse Transcriptase Inhibitors; Risk Factors; Serum Albumin	2006
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet (London, England), 1996, Nov-02, Volume: 348, Issue:9036 Topics: DNA, Viral; Fibrosis; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Failure; Liver Transplantation; Recurrence	1996
Lamivudine treatment for fulminant hepatic failure due to acute exacerbation of chronic hepatitis B infection. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:11 Topics: Administration, Oral; Adult; Aged; Comorbidity; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Failure; Male; Middle Aged; Reverse Transcriptase Inhibitors; Treatment Outcome	2001
Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 38, Issue:5 Topics: Adolescent; Adult; Alanine Transaminase; Anti-Inflammatory Agents; Antilymphocyte Serum; Bilirubin; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Liver Failure; Male; Methylprednisolone; Middle Aged; Prothrombin Time; Treatment Outcome; Virus Activation	2001

Other Studies

48 other study(ies) available for lamivudine and Liver Failure

Article	Year
Liver transplantation in hepatitis B core-negative recipients using livers from hepatitis B core-positive donors: a 13-year experience. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2013, Volume: 19, Issue:6 Topics: Adult; Aged; DNA, Viral; Female; Follow-Up Studies; Graft Survival; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver; Liver Failure; Liver Transplantation; Male; Middle Aged; Time Factors; Tissue Donors; Treatment Outcome	2013
Clinical events after cessation of lamivudine therapy in patients recovered from hepatitis B flare with hepatic decompensation. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2015, Volume: 13, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Cohort Studies; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Retrospective Studies; Withholding Treatment; Young Adult	2015
De novo hepatitis B virus infection after pediatric liver transplantations with hepatitis B core antibody-positive donors: a single-center 20-yr experience. Pediatric transplantation, 2015, Volume: 19, Issue:3 Topics: Adolescent; Child; Child, Preschool; Female; Graft Survival; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Incidence; Lamivudine; Liver Failure; Liver Transplantation; Living Donors; Male; Proportional Hazards Models; Republic of Korea; Retrospective Studies; Risk Factors	2015
Efficacy and safety of lamivudine or tenofovir plus intramuscular hepatitis B immunoglobulin in prevention of hepatitis B virus reinfection after liver transplant. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2015, Volume: 13 Suppl 1 Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Prospective Studies; Recurrence; Tenofovir; Time Factors; Treatment Outcome; Virus Activation; Young Adult	2015
Rhabdomyolysis due to lamivudine re-administration in a patient with HBV-related hepatic failure caused by interruption of lamivudine and adefovir. Journal of gastrointestinal and liver diseases : JGLD, 2015, Volume: 24, Issue:4 Topics: Adenine; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure; Male; Medication Adherence; Middle Aged; Organophosphonates; Rhabdomyolysis	2015
Risks and treatment strategies for de novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation. Pediatric transplantation, 2017, Volume: 21, Issue:2 Topics: Adolescent; Adult; Allografts; Child; Child, Preschool; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Infant; Lamivudine; Liver Failure; Liver Transplantation; Living Donors; Male; Middle Aged; Retrospective Studies; Risk Factors; Tissue Donors; Young Adult	2017
Predictive factors associated with the progression to hepatic failure caused by lamivudine-resistant HBV. Digestive diseases and sciences, 2008, Volume: 53, Issue:11 Topics: Adenine; Adult; Antiviral Agents; Bilirubin; Disease Progression; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Patient Selection; Predictive Value of Tests; Prognosis; Prothrombin Time; Retrospective Studies; Treatment Outcome	2008
Chronic cirrhotic hepatitis B patients with a high incidence of hepatic decompensation after viral breakthrough with lamivudine-resistant mutants and during rescue treatment. Scandinavian journal of gastroenterology, 2008, Volume: 43, Issue:12 Topics: Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Liver Cirrhosis; Liver Failure; Male; Middle Aged	2008
Costs and efficacy of "on demand" low-dose immunoprophylaxis in HBV transplanted patients: experience in the Romanian program of liver transplantation. Journal of gastrointestinal and liver diseases : JGLD, 2008, Volume: 17, Issue:4 Topics: Adult; Comorbidity; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis D; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunotherapy; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Program Evaluation; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Romania; Survival Analysis; Treatment Outcome	2008
[Lamivudine, interferon-alpha and oxymatrine treatment for the surviving hepatic failure patients with hepatitis B]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:7 Topics: Adolescent; Adult; Alkaloids; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Liver Failure; Liver Function Tests; Male; Matrines; Middle Aged; Quinolizines; Treatment Outcome; Young Adult	2009
Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2010, Volume: 10, Issue:5 Topics: Adult; Aged; Antiviral Agents; Graft Survival; Hepatitis; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Immunoglobulins; Immunologic Deficiency Syndromes; Infections; Lamivudine; Liver Cirrhosis; Liver Failure; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Secondary Prevention; Treatment Outcome; Virus Diseases; Viruses	2010
Long-term results of hepatitis B immunoglobulin and lamuvidine for hepatitis B prophylaxis after liver transplantation. Transplantation proceedings, 2011, Volume: 43, Issue:2 Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors	2011
Entecavir versus lamivudine in the treatment of chronic hepatitis B patients with hepatic decompensation. Antiviral therapy, 2012, Volume: 17, Issue:4 Topics: Adult; Antiviral Agents; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome	2012
Severe acute exacerbation of chronic hepatitis B during pegylated interferon treatment and early intervention with corticosteroid. Virology journal, 2012, Jul-24, Volume: 9 Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Antiviral Agents; Early Medical Intervention; Hepatitis B, Chronic; Humans; Immunologic Factors; Interferon-alpha; Lamivudine; Liver Failure; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Treatment Outcome; Young Adult	2012
Acute lymphoblastic leukemia in the context of a disorder resembling X-linked lymphoproliferative (XLP) syndrome. Haematologica, 2002, Volume: 87, Issue:8 Topics: Adolescent; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Burkitt Lymphoma; Carrier Proteins; Daunorubicin; Fatal Outcome; Genetic Heterogeneity; Granulocyte Colony-Stimulating Factor; Herpesvirus 4, Human; Humans; Infectious Mononucleosis; Intracellular Signaling Peptides and Proteins; Lamivudine; Lenograstim; Liver Failure; Lymphoproliferative Disorders; Male; Mucormycosis; Pleural Effusion; Prednisone; Recombinant Proteins; Signaling Lymphocytic Activation Molecule Associated Protein; Tumor Virus Infections; Vincristine	2002
Negligence. Liver transplant patient too late to sue Viramune maker. AIDS policy & law, 2003, Mar-28, Volume: 18, Issue:6 Topics: Drug Combinations; Drug Industry; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Liver Failure; Liver Transplantation; Malpractice; Nevirapine; Reverse Transcriptase Inhibitors; Zidovudine	2003
Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failure. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2003, Volume: 27, Issue:1 Topics: 2-Aminopurine; Adult; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Famciclovir; Fatal Outcome; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure; Reverse Transcriptase Inhibitors	2003
Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations. Haematologica, 2003, Volume: 88, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carrier State; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Antigens; Hepatitis B virus; Hepatitis C Antibodies; Humans; Lamivudine; Liver Failure; Lymphoma, Non-Hodgkin; Male; Middle Aged; Sequence Homology; Vidarabine; Virus Activation	2003
Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated. Zeitschrift fur Gastroenterologie, 2004, Volume: 42, Issue:1 Topics: Adenine; Adult; Anti-HIV Agents; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Genotype; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Failure; Liver Transplantation; Living Donors; Male; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors	2004
Adefovir dipivoxil as a treatment for hepatic failure caused by lamivudine-resistant HBV strains. Digestive diseases and sciences, 2004, Volume: 49, Issue:2 Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Organophosphonates; Retreatment; Reverse Transcriptase Inhibitors; Treatment Outcome	2004
Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation. Transplantation proceedings, 2004, Volume: 36, Issue:3 Topics: Antiviral Agents; Costs and Cost Analysis; Female; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins, Intravenous; Italy; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome	2004
Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with chemotherapy and rituximab: necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy. Leukemia & lymphoma, 2004, Volume: 45, Issue:3 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Lymphoma, Non-Hodgkin; Rituximab; Serologic Tests; Virus Activation	2004
The use of lamivudine for patients with acute hepatitis B (a series of cases). Journal of viral hepatitis, 2004, Volume: 11, Issue:5 Topics: Acute Disease; Adult; Aged; DNA, Viral; Female; Hepatitis B; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Renal Dialysis; Reverse Transcriptase Inhibitors; Severity of Illness Index; Treatment Outcome	2004
Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2004, Volume: 10, Issue:11 Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Graft Survival; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Organophosphonates; Recurrence; Retrospective Studies; Survival Analysis; Treatment Outcome	2004
Survival of infantile fulminant hepatitis B and treatment with Lamivudine. Journal of pediatric gastroenterology and nutrition, 2005, Volume: 40, Issue:4 Topics: Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant; Lamivudine; Liver Failure; Male; Reverse Transcriptase Inhibitors; Survival Analysis; Treatment Outcome	2005
Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine. Hepatology (Baltimore, Md.), 2005, Volume: 42, Issue:1 Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Failure; Liver Neoplasms; Male; Middle Aged; Nucleosides; Nucleotides; Organophosphonates; Retrospective Studies; Survival Analysis; Treatment Outcome	2005
Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations. Leukemia & lymphoma, 2005, Volume: 46, Issue:7 Topics: Aged; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fatal Outcome; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Lymphoma, B-Cell; Male; Prednisone; Rituximab; Vincristine; Virus Activation	2005
[Prevention and treatment of hepatitis B virus reinfection after liver transplantation]. Zhonghua wai ke za zhi [Chinese journal of surgery], 2005, Aug-01, Volume: 43, Issue:15 Topics: Administration, Oral; Adult; Antiviral Agents; Carcinoma, Hepatocellular; Combined Modality Therapy; Female; Hepatitis B, Chronic; Humans; Immunization, Passive; Immunoglobulin G; Injections, Intramuscular; Lamivudine; Liver Failure; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Secondary Prevention	2005
Fatal liver failure with the emergence of hepatitis B surface antigen variants with multiple stop mutations after discontinuation of lamivudine therapy. Journal of medical virology, 2006, Volume: 78, Issue:3 Topics: Amino Acid Sequence; Amino Acid Substitution; Antiviral Agents; DNA, Viral; Fatal Outcome; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Molecular Sequence Data; Mutation	2006
Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2006, Volume: 12, Issue:2 Topics: Adult; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Hepatitis B, Chronic; Humans; Immunoglobulins; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Probability; Retrospective Studies; Risk Assessment; Secondary Prevention; Statistics, Nonparametric; Treatment Outcome	2006
Prophylactic use of low-dose, on-demand, intramuscular hepatitis B immunoglobulin and lamivudine after liver transplantation. Transplantation proceedings, 2006, Volume: 38, Issue:2 Topics: Antiviral Agents; DNA, Viral; Drug Administration Schedule; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver Failure; Liver Transplantation; Recurrence; Retrospective Studies; Time Factors	2006
Fatal liver failure caused by reactivation of lamivudine-resistant hepatitis B virus: a case report. World journal of gastroenterology, 2007, Feb-14, Volume: 13, Issue:6 Topics: Amino Acid Sequence; Antiviral Agents; Drug Resistance, Viral; Fatal Outcome; Gene Products, pol; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Molecular Sequence Data; Mutation	2007
Outcomes of patients with hepatitis B who developed antiviral resistance while on the liver transplant waiting list. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2007, Volume: 5, Issue:12 Topics: Disease Progression; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Prognosis; Prospective Studies; Retrospective Studies; Reverse Transcriptase Inhibitors; Survival Rate; United States; Waiting Lists	2007
Lamivudine resistance and other mutations in the polymerase and surface antigen genes of hepatitis B virus associated with a fatal hepatic failure case. Journal of gastroenterology and hepatology, 2008, Volume: 23, Issue:1 Topics: Amino Acid Sequence; Antiviral Agents; Chronic Disease; DNA, Viral; Drug Resistance, Viral; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Molecular Sequence Data; Mutation; RNA-Directed DNA Polymerase; Trans-Activators; Viral Regulatory and Accessory Proteins	2008
Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. Transplantation, 1996, Nov-27, Volume: 62, Issue:10 Topics: Adult; Female; Hepatitis B; Hepatitis, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Failure; Liver Transplantation; Male; Middle Aged; Neural Conduction; Pilot Projects; Treatment Outcome; Virus Replication	1996
Clinical implications of lamivudine resistance by HBV. Lancet (London, England), 1997, Jan-04, Volume: 349, Issue:9044 Topics: Antiviral Agents; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Immunocompetence; Lamivudine; Liver Failure; Liver Transplantation; Mutation	1997
Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet (London, England), 1997, Jan-04, Volume: 349, Issue:9044 Topics: Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Point Mutation; Polymerase Chain Reaction; Recurrence	1997
Lamivudine-stavudine-induced liver failure in hepatitis B cirrhosis. The American journal of gastroenterology, 1997, Volume: 92, Issue:9 Topics: Aged; Anti-HIV Agents; Ascites; Drug Combinations; Hepatitis B; Hepatitis, Chronic; HIV Infections; Humans; Jaundice; Lamivudine; Liver Cirrhosis; Liver Failure; Male; Reverse Transcriptase Inhibitors; Stavudine	1997
Lamivudine treatment for acute hepatitis B after liver transplantation. Journal of hepatology, 1998, Volume: 29, Issue:6 Topics: Acute Disease; Adult; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Recurrence	1998
Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome. Blood, 1999, Feb-01, Volume: 93, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Hemophilia A; Hepatitis C; HIV Protease Inhibitors; Humans; Lamivudine; Liver Failure; Liver Transplantation; Male; Stavudine; Viral Load	1999
Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin. Transplantation, 1999, Dec-27, Volume: 68, Issue:12 Topics: Adenine; Adult; Antiviral Agents; Carrier State; DNA-Directed DNA Polymerase; Drug Resistance; Female; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Kidney Transplantation; Lamivudine; Liver Failure; Liver Transplantation; Mutation; Organophosphonates	1999
Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy. Hepatology (Baltimore, Md.), 2000, Volume: 32, Issue:3 Topics: Adult; Drug Administration Schedule; Hepatitis B, Chronic; Humans; Jaundice; Lamivudine; Liver Failure; Male; Retreatment; Reverse Transcriptase Inhibitors; Time Factors	2000
Lamivudine therapy for a hepatitis B surface antigen (HBsAg)-positive leukemia patient receiving myeloablative chemotherapy and autologous stem cell transplantation. Bone marrow transplantation, 2000, Volume: 26, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Combined Modality Therapy; DNA, Viral; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Leukemia, Myeloid, Acute; Liver Failure; Male; Reverse Transcriptase Inhibitors	2000
Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures--worldwide, 1997-2000. MMWR. Morbidity and mortality weekly report, 2001, Jan-05, Volume: 49, Issue:51-52 Topics: Adult; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Female; HIV Infections; Humans; Lamivudine; Liver Failure; Male; Nevirapine; Occupational Exposure; Reverse Transcriptase Inhibitors; Rhabdomyolysis; Zidovudine	2001
Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in children. Transplantation, 2001, Jul-27, Volume: 72, Issue:2 Topics: 2-Aminopurine; Adolescent; Alanine Transaminase; Antiviral Agents; Child; Child, Preschool; Cystic Fibrosis; DNA, Viral; Famciclovir; Female; Hepatitis A; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Hyperoxaluria; Lamivudine; Liver Failure; Liver Transplantation; Living Donors; Male; Postoperative Complications; Retrospective Studies; Time Factors	2001
YMDD-mutant HBV strain as a cause of liver failure in an HIV-infected patient. Gastroenterology, 2001, Volume: 121, Issue:4 Topics: Adult; Drug Resistance, Microbial; Genotype; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Liver Failure; Male; Mutation; Reverse Transcriptase Inhibitors; Substance Abuse, Intravenous	2001
Fulminant hepatitis B due to a lamivudine-resistant mutant of HBV in a patient coinfected with HIV. Gastroenterology, 2002, Volume: 122, Issue:1 Topics: Anti-HIV Agents; Drug Resistance, Viral; Fatal Outcome; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Mutation	2002
Fatal hepatic failure after emergence of the hepatitis B virus mutant during lamivudine therapy in a patient with liver cirrhosis. Scandinavian journal of gastroenterology, 2002, Volume: 37, Issue:3 Topics: Base Sequence; DNA, Viral; Drug Resistance, Microbial; Fatal Outcome; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Failure; Male; Middle Aged; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors	2002